InsidersTradesSigma
Paxman AB (publ) Stock: price and directors' dealings · Finland · FIN-FSA
Track the Paxman AB (publ) stock price and the full management transaction log of the company, a publicly traded company based in Finland. Shares trade on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Paxman AB (publ) has logged 9 insider filings. Market capitalisation: €1.1bn. The latest transaction was filed on 26 June 2026 (Purchase). Among the most active insiders: Per-Anders Johansson. The full history is accessible without an account.
9
Insider Decl.
0
Thresholds
€344,429
7 ops.
Buy Volume
€303,796
2 ops.
Sell Volume
38Σ signal
Fundamental score
Ranked 18,845 of 25,921 companies
36.5
score / 100
Value22
Quality51
FCF yld-1.4%
Earn yld-1.5%
EV/EBITDA38.4x
ROE-3.3%
Gross mgn67%
Net mgn-5.3%
Debt/EBITDA0.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 26 June 2026
Declarations9 total
2,000 shares@ SEK 49.000.0008% mcap12.9% of flowAktieFI:csv-4c7b74818975a5239e50
Ideal exit: 22 Mar 2027 (T+270)
1,000 shares@ SEK 50.400.0004% mcap7.6% of flowAktieFI:csv-a621526c952869f67fb1
Ideal exit: 20 Mar 2027 (T+270)
7,000 shares@ SEK 50.000.0027% mcap53.0% of flowAktieFI:csv-840897785263bbefe04b
Ideal exit: 20 Mar 2027 (T+270)
1,000 shares@ SEK 51.300.0004% mcap20.1% of flowAktieFI:csv-78c2db0e6c150aede4e2
Ideal exit: 20 Feb 2027 (T+270)
60,000 shares@ SEK 50.000.022% mcap90.9% of flowAktieFI:csv-6e4cc0bd634a7811afd0
Ideal exit: 19 Feb 2027 (T+270)
60,000 shares@ SEK 50.000.022% mcap100.0% of flowAktieFI:csv-21b09a4f07a62c7f0bfe
3,000 shares@ SEK 50.000.0011% mcap58.5% of flowAktieFI:csv-2b4e49a275d041f258e2
Ideal exit: 15 Feb 2027 (T+270)
1,120 shares@ €4.46790.0004% mcap100.0% of flowAktieFI:A003X512-1
Ideal exit: 27 Dec 2026 (T+270)
11,250 shares@ SEK 24.90100.0% of flowAktieFI:A001P474-1
9 of 9 declarations
About Paxman AB (publ)
Paxman AB (publ) is a Swedish company focused on developing solutions for managing the side effects of chemotherapy. It is listed on the Stockholm Stock Exchange (XSTO).